NL Development PCL

NL Development PCL reports negative returns on equity (-1.89%) and assets (-1.07%), indicating underperformance relative to industry norms. The company maintains a strong liquidity position with a current ratio of 2.18 and THB 275.8 million in cash and equivalents. However, operating cash flow is negative at THB -34.8 million, and free cash flow is also negative at THB -29.2 million, suggesting operational inefficiencies. Profitability metrics show a gross margin of 11.45% (THB 133.2 million gross profit on THB 1.16 billion revenue), but operating and net income are negative at THB -14.7 million and THB -14.7 million, respectively. These figures fall below the median for the Construction & Engineering industry, which typically reports positive operating margins and ROIC above 10%. The company's revenue is concentrated in five construction segments: medical facilities, office and commercial buildings, residential buildings, special buildings, and other construction work. No geographic diversification is disclosed, with all operations based in Thailand. Outlook for FY2024 shows a projected revenue decline, with a negative delta of 5.2% year-over-year. The company has not disclosed specific growth initiatives or new project pipelines in recent filings. Historical revenue growth has been volatile, with a 12.3% decline in FY2023 compared to FY2022. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has a low debt-to-equity ratio of 0.01, and long-term debt is minimal at THB 10.5 million. No dilution sources were identified in recent 10-K filings or shelf registration statements. Recent events include the completion of the King Mongkut Chaokhunthahan Hospital and the Accident and Emergency Building, as disclosed in the latest annual report. No material regulatory or legal proceedings were reported in the last 12 months.